A groundbreaking shift in Canadian drug policy has taken place, as the government permit the use of psilocybin hallucinogens for therapeutic purposes. Before this, these substances were heavily restricted, but a growing body of research suggests they potentially offer aid for psychological conditions like PTSD. The new policy represents a substanti